Merck & Co. (MRK)
(Real Time Quote from BATS)
$125.60 USD
+0.16 (0.13%)
Updated Jul 17, 2024 09:48 AM ET
3-Hold of 5 3
C Value B Growth F Momentum C VGM
Brokerage Reports
Merck & Co., Inc. [MRK]
Reports for Purchase
Showing records 241 - 260 ( 398 total )
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for MRK
Provider: Stock Traders Daily
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for MRK
Provider: Stock Traders Daily
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for MRK.
Provider: Stock Traders Daily
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for MRK.
Provider: Stock Traders Daily
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Immuno-Oncology Key Opinion Leader Conference Call Recap
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R